Hjem › Ikke-småcellet lungekreft › New Jersey › Clifton
Kliniske studier for Ikke-småcellet lungekreft i Clifton, NJ
24 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Clifton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #105, Hackensack · 7 mi unna
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RekruttererFase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152), Hackensack · 7 mi unna
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruttererFase 3
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi unna
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekruttererFase 2
- Hackensack University Medical Center, Hackensack · 7 mi unna
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruttererFase 2/3
- John Theurer Cancer Center, Hackensack · 7 mi unna
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
RekruttererFase 2
- Hackensack Meridian Health, Hackensack · 7 mi unna
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
RekruttererFase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0035), Hackensack · 7 mi unna
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi unna
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi unna
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- John Theurer Cancer Center, Hackensack · 7 mi unna
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruttererFase 1
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack · 7 mi unna
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- John Theurer Cancer Center At Hackensack UMC, Hackensack · 7 mi unna
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
RAPA-201 Therapy of Solid Tumors
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Clifton
- Kreft (alle typer)15 studier
- Multipelt myelom14 studier
- Metastatisk kreft12 studier
- Akut myelogen leukemi12 studier
- Brystkreft12 studier
- Prostatakreft12 studier
- Eggstokkreft11 studier
- Lungekreft10 studier
- Kolorektal kreft8 studier
- Plateepitelcancer i hode og hals8 studier
- Endometriekreft8 studier
- Hjertesvikt8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.